Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108724314 | 10872431 | 4 | F | 20130227 | 20160719 | 20150226 | 20160725 | EXP | CA-ROCHE-1201015 | ROCHE | 60.22 | YR | F | Y | 100.00000 | KG | 20160725 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108724314 | 10872431 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | DOSE WAS INCREASED FROM 150MG TO 300MG | S0001E | 103976 | 300 | MG | SOLUTION FOR INJECTION | ||||||
| 108724314 | 10872431 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | S0001E | 103976 | 150 | MG | SOLUTION FOR INJECTION | |||||||
| 108724314 | 10872431 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | S0001E | 103976 | SOLUTION FOR INJECTION | |||||||||
| 108724314 | 10872431 | 4 | C | ZYLOPRIM | ALLOPURINOL | 1 | Unknown | 0 | 300 | MG | QD | ||||||||
| 108724314 | 10872431 | 5 | C | LYRICA | PREGABALIN | 1 | Unknown | 0 | 75 | MG | BID | ||||||||
| 108724314 | 10872431 | 6 | C | BACLOFEN. | BACLOFEN | 1 | Unknown | QHS | 0 | 10 | MG | ||||||||
| 108724314 | 10872431 | 7 | C | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | 0 | 1 | DF | QD | ||||||||
| 108724314 | 10872431 | 8 | C | TRYPTOPHAN | TRYPTOPHAN | 1 | Unknown | 0 | 1500 | MG | |||||||||
| 108724314 | 10872431 | 9 | C | TECTA | PANTOPRAZOLE MAGNESIUM | 1 | Unknown | 0 | 40 | MG | QD | ||||||||
| 108724314 | 10872431 | 10 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | 0 | 20 | MG | QD | ||||||||
| 108724314 | 10872431 | 11 | C | VOLTAREN | DICLOFENAC SODIUM | 1 | 0 | ||||||||||||
| 108724314 | 10872431 | 12 | C | INDERAL | PROPRANOLOL HYDROCHLORIDE | 1 | Unknown | INDERAL LA | 0 | 80 | MG | ||||||||
| 108724314 | 10872431 | 13 | C | OMNARIS | CICLESONIDE | 1 | 0 | ||||||||||||
| 108724314 | 10872431 | 14 | C | TARGIN | NALOXONE HYDROCHLORIDEOXYCODONE HYDROCHLORIDE | 1 | Unknown | 10/5 | 0 | 1 | DF | TABLET | BID | ||||||
| 108724314 | 10872431 | 15 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 108724314 | 10872431 | 1 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 108724314 | 10872431 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 108724314 | 10872431 | Anxiety | |
| 108724314 | 10872431 | Bronchospasm | |
| 108724314 | 10872431 | Depressed level of consciousness | |
| 108724314 | 10872431 | Fall | |
| 108724314 | 10872431 | Fatigue | |
| 108724314 | 10872431 | Feeling abnormal | |
| 108724314 | 10872431 | Fibula fracture | |
| 108724314 | 10872431 | Headache | |
| 108724314 | 10872431 | Influenza | |
| 108724314 | 10872431 | Initial insomnia | |
| 108724314 | 10872431 | Insomnia | |
| 108724314 | 10872431 | Lower respiratory tract infection | |
| 108724314 | 10872431 | Pain | |
| 108724314 | 10872431 | Pruritus generalised | |
| 108724314 | 10872431 | Scar | |
| 108724314 | 10872431 | Sleep apnoea syndrome | |
| 108724314 | 10872431 | Somnolence | |
| 108724314 | 10872431 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 108724314 | 10872431 | 1 | 20090707 | 20160105 | 0 | |
| 108724314 | 10872431 | 2 | 20160202 | 0 | ||
| 108724314 | 10872431 | 3 | 20160621 | 0 |